Waters Corporation Reports Strong Q3 2026 Results and Raises Full Year Guidance
Waters Corporation (WAT) delivered robust third-quarter 2026 financial results, reporting total revenue of $1.767 billion. This performance was driven by a 10% organic revenue growth in constant currency, fueled by strong demand in bioseparations and instrument replacement trends within the Analytical Sciences division. The company's adjusted EPS grew by 21% to $4.10, benefiting from top-line expansion and cost synergies. Following these results, management raised its full-year 2026 revenue guidance by $43 million, targeting a range between $6.479 billion and $6.497 billion. While the company faces temporary headwinds including elevated inventory levels of 160 days and integration costs related to recent acquisitions, it provided an optimistic framework for 2027, projecting margin expansion and mid-to-high single-digit organic growth.
Topics: bioseparations eps beat guidance raise organic revenue revenue growth